Jiaming Nest.Bio Zhangjiang Life Science Park Named Among 'Top 50 Ecological Innovation & Empowerment Platforms,' Multiple Portfolio Companies Listed in '2026 Future Healthcare 100'

Park CEO Liu Qingnan attended the award ceremony and accepted the award on behalf of the Park.

*The long image has been cropped. Click the original link to view the full version.

*This long image has been truncated. Click "Read Original Article" to view the original.

*The long image has been cropped. Click "Read Original Text" to view the full image.

• In-depth Incubation Services: ChaoSheng Laboratory is equipped with fully outfitted shared instruments and central core laboratories, flexibly customizable BSL-2 laboratories for molecular biology, biochemistry, analytical, and cell biology, as well as upstream R&D services, imaging platforms, and other multi-functional laboratory spaces. These facilities meet the experimental requirements across multidisciplinary fields such as molecular biology, biochemistry, and cell biology, empowering R&D teams to rapidly initiate projects, complete proof-of-concept studies, and accelerate the translation from technology to products.
  
  
• `Space Acceleration Service`：Designed in a courtyard-style layout, the park comprises one 11-story main building and four exclusive detached buildings. It not only offers R&D spaces featuring a 5-meter ceiling height and flexible partitioning, alongside a premium environment with WELL Gold Certification, but also boasts a highly convenient geographic location—just a 10-minute walk to Kangxin Highway Metro Station and a 15-minute drive to the core area of Zhangjiang Pharma Valley. Furthermore, within a radius of over ten kilometers, the area hosts premier clinical and research institutions such as Shanghai International Medical Center, Shanghai Proton and Heavy Ion Center, National Children's Medical Center, and Fudan University Shanghai Cancer Center, underscoring its significant industrial cluster advantages.
  
  
• Capital Linkage Empowerment：Leveraging investment institutions such as Sherpa Capital, Boxing Capital, Chao Capital, and Tonghe Yucheng, the park has cultivated a robust industrial resource ecosystem. Meanwhile, the investment team's profound industry insights enable the park to identify the technological value of early-stage enterprises, and through capital injection and post-investment management, accelerate the commercialization of scientific and technological achievements.